Skip to main content
Premium Trial:

Request an Annual Quote

Epizyme, Eisai, Roche Partner to Develop CDx for Investigational Lymphoma Treatment

NEW YORK (GenomeWeb News) — Epizyme today announced a collaboration with Eisai and Roche to develop an in vitro, PCR-based companion diagnostic test to help treat genetically defined lymphomas.

The goal of the project, Epizyme said, is to identify lymphoma patients with non-wild type EZH2, including the Y641 mutation. In a study published in September in Nature Chemical Biology, Epizyme researchers demonstrated that lymphomas with genetic alterations of EZH2 require H3K27 methylation activity to proliferate, suggesting that EZH2 is a driving oncogene in these cancers and thus a potential therapeutic target.

Eisai and Epizyme are working together to develop an EZH2 inhibitor as a personalized therapeutic for patients, while Roche will develop a PCR-based assay to detect mutations in the gene to potentially select patients for therapy with the inhibitor.

Additional details of the partnership were not disclosed.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.